TechnologyJuly 14, 2026
biosimilar
/ˌbaɪoʊˈsɪmələr/
Definition
A biological medical product that is highly similar to an already approved reference product, having no clinically meaningful differences in safety, purity, or potency.
Etymology
Derived from the prefix 'bio-' (relating to life or biology) and the adjective 'similar.' It was coined in the late 20th century to distinguish these products from 'generics,' which are identical to chemical drugs.
In the news
The term appears in the news list sidebar regarding regulatory changes to approval requirements. It refers to a category of drugs that undergo a streamlined path to market compared to the original biologic medicines.
Noul's miLab MAL highlighted as leading AI malaria diagnostic in Harvard-led international study
Read the full article ↗koreabiomed.com